The assumption to check
Are registration, a code, and approval the same thing?
A clearer starting point
A registered maker or a drug code does not prove medicine approval.
Start with the finished medicine
The Food and Drug Administration (FDA) regulates drugs in the US.
Semaglutide and tirzepatide have uses in weight loss and type 2 diabetes care. Their FDA-approved products include Ozempic and Wegovy for semaglutide, and Mounjaro and Zepbound for tirzepatide (checked September 2026).
An ingredient name on a page does not identify the finished medicine being offered. Ask for the product name and form.
Registration is a separate step
Federal rules say a maker’s registration or a drug’s listing is not FDA approval. Neither proves the drug may legally be sold (checked September 2026).
If a care page says FDA registered, ask what is registered. The facility and the medicine are different subjects.
A drug code is not proof of approval
A product listing in the FDA’s drug list has a National Drug Code, or NDC, to identify it. The FDA says that code does not prove drug approval or that it checked the listing’s information (checked September 2026).
Ask for the medicine’s approval record as well as its code. A number on its own does not answer the approval question.
Compounded and generic are different words
A generic has approval as a copy of a brand medicine; a compounded drug is made to order.
As of September 2026, the FDA says calling a compounded drug the generic version of an approved product misleads people.
The September 2026 check found no FDA-approved generic for semaglutide or tirzepatide that was permitted to be sold in the US.
Ask which approval record supports a generic claim. Do not let the word stand in for the record.